Aortic valve sclerosis: Is it a cardiovascular risk factor or a cardiac disease marker?

Echocardiography

Volumn 24, Issue 3, 2007, Pages 217-221

  Palmiero, Pasquale ^a   Maiello, Maria ^a   Passantino, Andrea ^b   Wasson, Sanjeev ^c   Reddy, Hanumanth K ^d  

^a ASLBR 1   (Italy)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^c UNIVERSITY OF MISSOURI   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Aortic sclerosis; Left ventricular hypertrophy; Myocardial infarction; Systolic heart failure; Ventricular arrhythmias

Indexed keywords

CHOLESTEROL;

ADULT; AGED; AORTA ATHEROSCLEROSIS; AORTA VALVE; AORTA VALVE DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC HEART FAILURE; DISEASE MARKER; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE ARRHYTHMIA; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SMOKING; STATISTICAL SIGNIFICANCE; STROKE; SYSTOLIC HEART FAILURE;

AGED; AORTIC VALVE; ARRHYTHMIA; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART FAILURE, CONGESTIVE; HEART VALVE DISEASES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MYOCARDIAL INFARCTION; PREVALENCE; RISK FACTORS;

EID: 33847093008     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2007.00379.x     Document Type: Article

References (36)

1. Otto CM: Aortic stenosis. Clinical evaluation and optimal timing of surgery. Cardiol Clin 1998;16(3):353-373.
2. Datta BN, Bhusnurmath B, Khattri HN, et al: Anatomically isolated aortic valve disease. Morphologic study of 100 cases at autopsy. Jpn Heart J 1988;29(5):661-670.
3. D'Cruz I, Panetta F, Cohen H, et al: Submitral calci-fication or sclerosis in elderly patients: M mode and two dimensional echocardiography in "mitral anulus calcification." Am J Cardiol 1979;44(1):31-38.
4. D'Cruz IA, Devaraj N, Hirsch LJ, et al: Unusual echocardiographic appearances attributable to submitral calcification simulating left ventricular "masses." Clin Cardiol 1980;3(4):260-264.
5. Berko BA, Owen AN, Zwas DR: Echocardiography. The role of this noninvasive test in the geriatric population. Geriatrics 2003;58(7):30-34.
6. Mellino M, Salcedo EE, Lever HM, et al: Echographic-quantified severity of mitral anulus calcification: Prognostic correlation to related hemodynamic, valvular, rhythm, and conduction abnormalities. Am Heart J 1982;103(2):222-225.
7. Popovic AD, Stewart WJ: Echocardiographic evaluation of valvular stenosis: The gold standard for the next millennium? Echocardiography 2001;18(1):59-63.
8. Prasad Y, Bhalodkar NC: Aortic sclerosis - a marker of coronary atherosclerosis. Clin Cardiol 2004;27(12):671-673.
9. Rubler S, King ML, Tarkoff DM, et al: The role of aortic valve calcium in the detection of aortic stenosis: An echocardiographic study. Am Heart J 1985;109(5 Pt 1):1049-1058.
10. Beppu S, Suzuki S, Matsuda H, et al: Rapidity of progression of aortic stenosis in patients with congenital bicuspid aortic valves. Am J Cardiol 1993;71(4):322-327.
11. Nassimiha D, Aronow WS, Ahn C, et al: Association of coronary risk factors with progression of valvular aortic stenosis in older persons. Am J Cardiol 2001;87(11):1313-1314.
12. Otto CM: Why is aortic sclerosis associated with adverse clinical outcomes? J Am Coll Cardiol 2004;43(2):176-178.
13. Gustafsson C, Britton M, Brolund F, et al: Echocardiographic findings and the increased risk of stroke in nonvalvular atrial fibrillation. Cardiology 1992;81(4-5):189-195.
14. Aronow WS, Ahn C, Kronzon I: Association of valvular aortic stenosis with symptomatic peripheral arterial disease in older persons. Am J Cardiol 2001;88(9):1046-1047.
15. Yamaura Y, Nishida T, Watanabe N, et al: Relation of aortic valve sclerosis to carotid artery intimamedia thickening in healthy subjects. Am J Cardiol 2004;94(6):837-839.
16. Pohle K, Maffert R, Ropers D, et al: Progression of aortic valve calcification: Association with coronary atherosclerosis and cardiovascular risk factors. Circulation 2001;104(16):1927-1932.
17. Shavelle DM, Takasu J, Budoff MJ, et al: HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet 2002;359(9312):1125-1126.
18. Carabello BA: Aortic sclerosis - a window to the coronary arteries? N Engl J Med 1999;341(3):193-195.
19. Achuff SC, Baumgartner WA: Aortic-valve sclerosis. N Engl J Med 1999;341(24):1856-1857.
20. Getchell WS: Aortic-valve sclerosis. N Engl J Med 1999;341(24):1856; author reply 1856-1857.
21. Kim DK, Rajput V: Aortic-valve sclerosis. N Engl J Med 1999;341(24):1856; author reply 1856-1857.
22. Chandra HR, Goldstein JA, Choudhary N, et al: Adverse outcome in aortic sclerosis is associated with coronary artery disease and inflammation. J Am Coll Cardiol 2004;43(2):169-175.
23. Hsu SY, Hsieh IC, Chang SH, et al: Aortic valve sclerosis is an echocardiographic indicator of significant coronary disease in patients undergoing diagnostic coronary angiography. Int J Clin Pract 2005;59(1):72-77.
24. Olsen MH, Wachtell K, Bella JN, et al: Aortic valve sclerosis relates to cardiovascular events in patients with hypertension (a LIFE substudy). Am J Cardiol 2005;95(1):132-136.
25. Tolstrup K, Crawford MH, Roldan CA: Morphologic characteristics of aortic valve sclerosis by transesophageal echocardiography: Importance for the prediction of coronary artery disease. Cardiology 2002;98(3):154-158.
26. Chan KL: Is aortic stenosis a preventable disease? J Am Coll Cardiol 2003;42(4):593-599.
27. Gotoh T, Kuroda T, Yamasawa M, et al: Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study). Am J Cardiol 1995;76(12):928-932.
28. Otto CM, Lind BK, Kitzman DW, et al: Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999;341(3):142-147.
29. European Study Group on Diastolic Heart Failure: How to diagnose diastolic heart failure. Eur Heart J 1998;19(7):990-1003.
30. Stewart BF, Siscovick D, Lind BK, et al: Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997;29(3):630-634.
31. Nemes A, Forster T, Varga A, et al: How can coronary flow reserve be altered by severe aortic stenosis? Echocardiography 2002;19(8):655-659.
32. Poggianti E, Venneri L, Chubuchny V, et al: Aortic valve sclerosis is associated with systemic endothelial dysfunction. J Am Coll Cardiol 2003;41(1):136-141.
33. Agmon Y, Khandheria BK, Jamil Tajik A, et al: In-flammation, infection, and aortic valve sclerosis: Insights from the Olmsted County (Minnesota) population. Atherosclerosis 2004;174(2):337-342.
34. Olsen MH, Wachtell K, Bella JN, et al: Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy). Am J Cardiol 2004;94(8):1076-1080.
35. Agmon Y, Khandheria BK, Meissner I, et al: Aortic valve sclerosis and aortic atherosclerosis: Different manifestations of the same disease? Insights from a population-based study. J Am Coll Cardiol 2001;38(3):827-834.
36. Jeon DS, Atar S, BraschAV, et al: Association of mitral annulus calcification, aortic valve sclerosis and aortic root calcification with abnormal myocardial perfusion single photon emission tomography in subjects age ≤ 65 years old. J Am Coll Cardiol 2001;38(7):1988-1993.